Deep sequence analysis of non-small cell lung cancer: Integrated analysis of gene expression, alternative splicing, and single nucleotide variations in lung adenocarcinomas with and without oncogenic KRAS mutations

Frontiers in Oncology

Volumn 2, Issue FEB, 2012, Pages

  Kalari, Krishna R ^a,b   Rossell, David ^c   Necela, Brian M ^b   Asmann, Yan W ^a   Nair, Asha ^a   Baheti, Saurabh ^a   Kachergus, Jennifer M ^b   Younkin, Curtis S ^b   Baker, Tiffany ^b   Carr, Jennifer M ^b   Tang, Xiaojia ^b   Walsh, Michael P ^b   Chai, High Seng ^a   Sun, Zhifu ^a   Hart, Steven N ^a   Leontovich, Alexey A ^a   Hossain, Asif ^a   Kocher, Jean Pierre ^a   Perez, Edith A ^b   Reisman, David N ^d   Fields, Alan P ^b   Thompson, E Aubrey ^b   more..

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

^c INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Spain)

^d UNIVERSITY OF FLORIDA   (United States)

Author keywords

Bioinformatics; Data integration and computational methods; KRAS mutation; Network analysis; NSCLC; RNA Seq; Transcriptome sequencing

Indexed keywords

CARBOPLATIN; CETUXIMAB; DNA; ERLOTINIB; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; K RAS PROTEIN; METFORMIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PAZOPANIB; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA ANTAGONIST; PHOSPHATIDYLINOSITOL 3 KINASE; PIOGLITAZONE; PROTEIN KINASE B; ROSIGLITAZONE; STRESS ACTIVATED PROTEIN KINASE; TIGATUZUMAB; TRANSCRIPTOME; TROGLITAZONE; TUMOR NECROSIS FACTOR INHIBITOR; TUMOR NECROSIS FACTOR RECEPTOR;

ALTERNATIVE RNA SPLICING; ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; REAL TIME POLYMERASE CHAIN REACTION; RNA SEQUENCE; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84870899165     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2012.00012     Document Type: Article

References (32)

1. Almoguera, C., Shibata, D., Forrester, K., Martin, J., Arnheim, N., and Perucho, M. (1988). Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53, 549-554.
2. Andreyev, H. J., Tilsed, J. V., Cunningham, D., Sampson, S. A., Norman, A. R., Schneider, H. J., and Clarke, P. A. (1997). K-ras mutations in patients with early colorectal cancers. Gut 41, 323-329.
3. Assenov, Y., Ramirez, F., Schelhorn, S. E., Lengauer, T., and Albrecht, M. (2008). Computing topological parameters of biological networks. Bioinformatics 24, 282-284.
4. Beane, J., Vick, J., Schembri, F., Anderlind, C., Gower, A., Campbell, J., Luo, L., Zhang, X. H., Xiao, J., Alekseyev, Y. O., Wang, S., Levy, S., Massion, P. P., Lenburg, M., and Spira, A. (2011). Characterizing the impact of smoking and lung cancer on the airway transcriptome using RNA-Seq. Cancer Prev. Res. (Phila.) 4, 803-817.
5. Beer, D. G., Kardia, S. L., Huang, C. C., Giordano, T. J., Levin, A. M., Misek, D. E., Lin, L., Chen, G., Gharib, T. G., Thomas, D. G., Lizyness, M. L., Kuick, R., Hayasaka, S., Taylor, J. M., Iannettoni, M. D., Orringer, M. B., and Hanash, S. (2002). Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat. Med. 8, 816-824.
6. Bild, A. H., Yao, G., Chang, J. T., Wang, Q., Potti, A., Chasse, D., Joshi, M. B., Harpole, D., Lancaster, J. M., Berchuck, A., Olson, J. A. Jr., Marks, J. R., Dressman, H. K., West, M., and Nevins, J. R. (2006). Oncogenic pathway signatures in human cancers as a guide to targeted therapies. Nature 439, 353-357.
7. Blasco, R. B., Francoz, S., Santamaria, D., Canamero, M., Dubus, P., Charron, J., Baccarini, M., and Barbacid, M. (2011). c-Raf, but not B-Raf, is essential for development of K-Ras oncogene-driven non-small cell lung carcinoma. Cancer Cell 19, 652-663.
8. Blumenschein, G. R. Jr., Gatzemeier, U., Fossella, F., Stewart, D. J., Cupit, L., Cihon, F., O'leary, J., and Reck, M. (2009). Phase II, multicenter, uncontrolled trial of single-agent sorafenib in patients with relapsed or refractory, advanced non-small-cell lung cancer. J. Clin. Oncol. 27, 4274-4280.
9. Dempster, A. P., Laird, N. M., and Rubin, D. B. (1977). Maximum likelihood from incomplete data via the EM algorithm. J. Roy. Stat. Soc. B Met. 39, 1-38.
10. Drosopoulos, K. G., Roberts, M. L., Cermak, L., Sasazuki, T., Shirasawa, S., Andera, L., and Pintzas, A. (2005). Transformation by oncogenic RAS sensitizes human colon cells to TRAIL-induced apoptosis by up-regulating death receptor 4 and death receptor 5 through a MEK-dependent pathway. J. Biol. Chem. 280, 22856-22867.
11. Eberhard, D. A., Johnson, B. E., Amler, L. C., Goddard, A. D., Heldens, S. L., Herbst, R. S., Ince, W. L., Janne, P. A., Januario, T., Johnson, D. H., Klein, P., Miller, V. A., Ostland, M. A., Ramies, D. A., Sebisanovic, D., Stinson, J. A., Zhang, Y. R., Seshagiri, S., and Hillan, K. J. (2005). Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib. J. Clin. Oncol. 23, 5900-5909.
12. Fujita, P. A., Rhead, B., Zweig, A. S., Hinrichs, A. S., Karolchik, D., Cline, M. S., Goldman, M., Barber, G. P., Clawson, H., Coelho, A., Diekhans, M., Dreszer, T. R., Giardine, B. M., Harte, R. A., Hillman-Jackson, J., Hsu, F., Kirkup, V., Kuhn, R. M., Learned, K., Li, C. H., Meyer, L. R., Pohl, A., Raney, B. J., Rosenbloom, K. R., Smith, K. E., Haussler, D., and Kent, W. J. (2011). The UCSC Genome Browser database: update 2011. Nucleic Acids Res. 39, D876-D882.
13. Goya, R., Sun, M. G., Morin, R. D., Leung, G., Ha, G., Wiegand, K. C., Senz, J., Crisan, A., Marra, M. A., Hirst, M., Huntsman, D., Murphy, K. P., Aparicio, S., and Shah, S. P. (2010). SNVMix: predicting single nucleotide variants from next-generation sequencing of tumors. Bioinformatics 26, 730-736.
14. Ignatenko, N. A., Babbar, N., Mehta, D., Casero, R. A. Jr., and Gerner, E. W. (2004). Suppression of polyamine catabolism by activated Ki-ras in human colon cancer cells. Mol. Carcinog. 39, 91-102.
15. Ji, H., Houghton, A. M., Mariani, T. J., Perera, S., Kim, C. B., Padera, R., Tonon, G., McNamara, K., Marconcini, L. A., Hezel, A., El-Bardeesy, N., Bronson, R. T., Sugarbaker, D., Maser, R. S., Shapiro, S. D., and Wong, K. K. (2006). K-ras activation generates an inflammatory response in lung tumors. Oncogene 25, 2105-2112.
16. Langmead, B., Trapnell, C., Pop, M., and Salzberg, S. L. (2009). Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10, R25.
17. Li, H., and Durbin, R. (2009). Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754-1760.
18. Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., and Durbin, R. (2009). The sequence alignment/map format and SAM tools. Bioinformatics 25, 2078-2079.
19. Massarelli, E., Varella-Garcia, M., Tang, X., Xavier, A. C., Ozburn, N. C., Liu, D. D., Bekele, B. N., Herbst, R. S., and Wistuba, I. I. (2007). KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer. Clin. Cancer Res. 13, 2890-2896.
20. Meylan, E., Dooley, A. L., Feldser, D. M., Shen, L., Turk, E., Ouyang, C., and Jacks, T. (2009). Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma. Nature 462, 104-107.
21. Okudela, K., Hayashi, H., Ito, T., Yazawa, T., Suzuki, T., Nakane, Y., Sato, H., Ishi, H., Keqin, X., Masuda, A., Takahashi, T., and Kitamura, H. (2004). K-ras gene mutation enhances motility of immortalized airway cells and lung adenocarcinoma cells via Akt activation: possible contribution to non-invasive expansion of lung adenocarcinoma. Am. J. Pathol. 164, 91-100.
22. Pao, W., Miller, V. A., Politi, K. A., Riely, G. J., Somwar, R., Zakowski, M. F., Kris, M. G., and Varmus, H. (2005a). Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain. PLoS Med. 2, e73. doi:10.1371/journal.pmed.0020073
23. Pao, W., Wang, T. Y., Riely, G. J., Miller, V. A., Pan, Q., Ladanyi, M., Zakowski, M. F., Heelan, R. T., Kris, M. G., and Varmus, H. E. (2005b). KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib. PLoS Med. 2, e17. doi:10.1371/journal.pmed.0020017
24. Riely, G. J., Marks, J., and Pao, W. (2009). KRAS mutations in non-small cell lung cancer. Proc. Am. Thorac. Soc. 6, 201-205.
25. Rossell, D. (2010). "Quantifying alternative splicing from paired end reads", in Proceedings of the Eighteenth Annual International Conference on Intelligent Systems for Molecular Biology, Boston, MA.
26. Shields, J. M., Pruitt, K., Mcfall, A., Shaub, A., and Der, C. J. (2000). Understanding Ras: 'it ain't over 'til it's over'. Trends Cell Biol. 10, 147-154.
27. Singh, A., Greninger, P., Rhodes, D., Koopman, L., Violette, S., Bardeesy, N., and Settleman, J. (2009). A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survival. Cancer Cell 15, 489-500.
28. Smoot, M. E., Ono, K., Ruscheinski, J., Wang, P. L., and Ideker, T. (2011). Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 27, 431-432.
29. Sun, Z., Asmann, Y. W., Kalari, K. R., Bot, B., Eckel-Passow, J. E., Baker, T. R., Carr, J. M., Khrebtukova, I., Luo, S., Zhang, L., Schroth, G. P., Perez, E. A., and Thompson, E. A. (2011). Integrated analysis of gene expression, CpG island methylation, and gene copy number in breast cancer cells by deep sequencing. PLoS One 6, e17490. doi:10.1371/journal.pone.0017490
30. Trapnell, C., Williams, B. A., Pertea, G., Mortazavi, A., Kwan, G., Van Baren, M. J., Salzberg, S. L., Wold, B. J., and Pachter, L. (2010). Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 28, 511-515.
31. Vojtek, A. B., and Der, C. J. (1998). Increasing complexity of the Ras signaling pathway. J. Biol. Chem. 273, 19925-19928.
32. Wang, K., Li, M., and Hakonarson, H. (2010). ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38, e164.